Cargando…
Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial
BACKGROUND: Blood pressure, lipid, and glycemic control are essential for reducing cardiovascular disease (CVD) risk. Many health care systems have successfully shifted aspects of chronic disease management, including population-based outreach programs designed to address CVD risk factor control, to...
Autores principales: | Selby, Joe V, Schmittdiel, Julie A, Fireman, Bruce, Jaffe, Marc, Ransom, Laura J, Dyer, Wendy, Uratsu, Connie S, Reed, Mary E, Kerr, Eve A, Hsu, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438122/ https://www.ncbi.nlm.nih.gov/pubmed/22747998 http://dx.doi.org/10.1186/1472-6963-12-183 |
Ejemplares similares
-
Study protocol: The Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study
por: Heisler, Michele, et al.
Publicado: (2010) -
Patient Race/Ethnicity and Patient-Physician Race/Ethnicity Concordance in the Management of Cardiovascular Disease Risk Factors for Patients With Diabetes
por: Traylor, Ana H., et al.
Publicado: (2010) -
Adherence to Cardiovascular Disease Medications: Does Patient-Provider Race/Ethnicity and Language Concordance Matter?
por: Traylor, Ana H., et al.
Publicado: (2010) -
The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators
por: Lester, Helen, et al.
Publicado: (2010) -
Initial Persistence With Antihypertensive Therapies Is Associated With Depression Treatment Persistence, But Not Depression
por: Schmittdiel, Julie A., et al.
Publicado: (2014)